Science · Article
How Vaccines Work: The Science, Main Types and History Explained
Published:

In brief
Vaccines train the immune system to recognize a disease-causing germ by exposing it to a harmless piece of that germ, called an antigen, so the body can respond faster if it meets the real pathogen later. Health agencies group vaccines into several platforms — including live-attenuated, inactivated, subunit, toxoid, conjugate, viral vector and mRNA — each delivering the antigen in a different way. The approach dates back to Edward Jenner's 1796 smallpox experiment and underpins the 1980 global eradication of smallpox.
Vaccines work by showing the immune system a harmless version of a pathogen's antigen — the part of a bacterium or virus that the body recognizes as foreign — according to the World Health Organization's European regional office. This exposure trains the immune system without causing the disease itself.
The immune mechanism
When the immune system meets an antigen, white blood cells called B-lymphocytes produce antibodies shaped to bind to that specific antigen, WHO Europe explains. These antibodies can block the pathogen directly or mark it for destruction by other immune cells such as phagocytes.
The immune system also keeps 'memory' cells after this encounter. WHO Europe notes that an unvaccinated person's first natural infection can take seven to twelve days before the body mounts an effective defense — a delay during which severe illness or death can occur. Vaccination allows the memory response to form in advance, so a later encounter with the real pathogen triggers a faster, stronger reaction. WHO Europe adds that immunity from this memory can last for years, decades or a lifetime, though it stresses that routine vaccines are 'very effective' but 'none is 100% effective,' which is why some vaccines require multiple doses.
Active versus passive immunity
The CDC's Pink Book, the agency's reference manual on vaccine-preventable diseases, distinguishes two routes to immunity. Passive immunity comes from antibodies made by another source, such as a fetus receiving maternal antibodies during pregnancy; it gives immediate but temporary protection that fades over weeks to months. Active immunity develops when a person's own immune system responds — either to a natural infection or to a vaccine — and, because of immunologic memory, it typically lasts for years or a lifetime.
Main vaccine types
The CDC Pink Book groups most traditional vaccines into two broad categories. Live-attenuated vaccines contain a weakened form of the virus or bacterium that still replicates in the body, producing an immune response the Pink Book describes as 'virtually identical' to a natural infection; these typically need only one injected dose. Inactivated vaccines cannot replicate and come in several subtypes: whole-cell vaccines use a killed pathogen (examples include polio, hepatitis A and rabies vaccines); subunit vaccines use only protective pieces of the organism (influenza, pneumococcal); toxoid vaccines use an inactivated bacterial toxin (diphtheria, tetanus); conjugate vaccines chemically attach a polysaccharide to a protein to improve response in young children; and recombinant vaccines use DNA technology to produce specific antigens (hepatitis B, HPV).
Two newer platforms were used widely during the COVID-19 pandemic. The CDC's COVID-19 vaccine guidance explains that mRNA vaccines, used in the Pfizer-BioNTech and Moderna shots, deliver lab-made genetic instructions that direct muscle cells to briefly produce a harmless piece of the virus's spike protein; the immune system then reacts to that displayed protein before the mRNA itself is broken down and cleared by the body. Protein subunit vaccines, such as Novavax's, instead inject the spike protein piece directly along with an adjuvant that strengthens the immune response.
| Type | How it works | Example diseases |
|---|---|---|
| Live-attenuated | Weakened live pathogen replicates briefly in the body | Measles, mumps, rubella (per CDC Pink Book) |
| Inactivated whole-cell | Killed pathogen cannot replicate | Polio, hepatitis A, rabies (CDC) |
| Subunit / recombinant | Only protective protein pieces, made via DNA technology | Hepatitis B, HPV, influenza (CDC) |
| Toxoid | Inactivated bacterial toxin | Diphtheria, tetanus (CDC) |
| Conjugate | Polysaccharide linked to a protein carrier | Pediatric bacterial vaccines (CDC) |
| mRNA | Genetic instructions make cells display a viral protein piece | COVID-19, Pfizer-BioNTech/Moderna (CDC) |
| Protein subunit with adjuvant | Direct injection of viral protein plus adjuvant | COVID-19, Novavax (CDC) |
Origins: from variolation to Jenner's vaccine
The practice of deliberately exposing people to a mild form of a disease to prevent a severe case predates modern vaccination by centuries. WHO's history of vaccination resource states that variolation — using material from smallpox sores to induce a milder infection — may date back as early as 200 BCE, with documented techniques in China by the mid-1500s and in India by the 18th century. Lady Mary Wortley Montagu introduced the practice to Europe in 1721 after observing it in the Ottoman Empire, and in the American colonies the technique, known through enslaved West Africans, was publicized by Cotton Mather during a 1721 Massachusetts outbreak.
The modern vaccine emerged in May 1796, when English physician Edward Jenner inoculated eight-year-old James Phipps with material from a cowpox sore on the hand of milkmaid Sarah Nelmes, according to WHO's history page. Two months later, in July 1796, Jenner deliberately exposed Phipps to smallpox matter; Phipps did not develop the disease, making him, in WHO's account, 'the first person to be vaccinated against smallpox.' By 1801 further testing had confirmed the method's effectiveness.
From mandatory vaccination to global eradication
According to WHO, mandatory smallpox vaccination began in Britain and parts of the United States in the 1840s and 1850s. In the 1950s, a heat-stable, freeze-dried version of the vaccine removed the need for constant refrigeration, aiding wider distribution. WHO called for global smallpox eradication in 1958, and the Intensified Smallpox Eradication Programme began in 1967 using a freeze-dried vaccine developed in the Soviet Union.
The disease was eliminated region by region: from South America in 1971, from Asia in 1975 and from Africa in 1977, WHO's timeline states. The World Health Organization officially declared smallpox eradicated in 1980 — the only human disease eliminated through vaccination to date, per WHO's account.
The first person to be vaccinated against smallpox.
Questions
- What is an antigen and why does it matter for vaccines?
- An antigen is the part of a bacterium or virus that the immune system recognizes as foreign, according to WHO Europe. Vaccines deliver a harmless version or piece of an antigen so the immune system can learn to recognize the real pathogen later.
- How long does vaccine-induced immunity last?
- WHO Europe states that immunity built through immune memory can last for years, decades or a lifetime, but adds that no routine vaccine is 100% effective, which is why several vaccines require multiple doses.
- What is the difference between mRNA and viral protein subunit vaccines?
- Per the CDC, mRNA vaccines deliver genetic instructions that make a person's own cells briefly produce a piece of a viral protein, while protein subunit vaccines inject that protein piece directly along with an adjuvant to boost the immune response.
- Who created the first vaccine and when?
- English physician Edward Jenner is credited with the first vaccine, inoculating eight-year-old James Phipps with cowpox matter in May 1796 and later confirming protection against smallpox in July 1796, according to WHO's history of vaccination.
- Has any disease been eradicated through vaccination?
- Yes. The World Health Organization declared smallpox eradicated in 1980 after a global vaccination campaign that eliminated the disease region by region between 1971 and 1977.
Sources
This piece was prepared with artificial intelligence and passed an automated source check before publication. If you see an error, ask for a correction. Request a correction or reply · How we make this
Related
ScienceNews
2026 Nobel Prize in Economics Goes to Robert Hall and Michael Woodford
The 2026 Nobel Prize in Economic Sciences has been awarded to American economists Robert E. Hall of Stanford University and Michael Woodford of Columbia University. The Royal Swedish Academy of Sciences honored them for building the "microeconomic foundations of macroeconomic stabilization," work now used by central banks worldwide to manage inflation, unemployment and economic shocks.
ScienceArticle
Africa's Turkana Rift: Why Scientists Say the Continent's Crust Is Thinner Than Thought
New seismic data show the crust along Kenya and Ethiopia's Turkana Rift has thinned to about 13 kilometers, less than half of what surrounding areas measure. Columbia University researchers say this means eastern Africa has entered "necking," an advanced, self-sustaining phase of continental breakup that could eventually produce a new ocean — though the process is expected to take several million more years.

ScienceNews
Margaret Hamilton, Apollo software pioneer who coined the term, dies at 90
Margaret Hamilton, who led the MIT team that wrote the onboard flight software for NASA's Apollo missions and is credited with coining the term "software engineering," died on September 30, 2026, at a hospital in Cambridge, Massachusetts. She was 90.
ScienceNews
USGS: Deep-Sea Sulfide Rocks Can Spontaneously Catch Fire in the Lab
A USGS-led team reports that iron-sulfide-rich rocks collected from the seafloor off the Oregon–California coast spontaneously combusted after being brought into a laboratory. The study, published in Scientific Reports, says the reaction poses a possible fire hazard for future deep-sea mining operations that has not been fully accounted for in current safety rules.